Correction: impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma.

Correction: impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma.

Bibliographic Details
Main Author:	PLOS ONE Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4395450?pdf=render

Similar Items

Impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma.
by: Yasuki Hori, et al.
Published: (2015-01-01)

Influence of TP53 Codon 72 Polymorphism Alone or in Combination with HDM2 SNP309 on Human Infertility and IVF Outcome.
by: Ying Chan, et al.
Published: (2016-01-01)

Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.
by: Shenying Fang, et al.
Published: (2010-05-01)

Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore
by: Sabapathy Kanaga, et al.
Published: (2010-03-01)

Analysis of TP53 Codon 72 Polymorphism in Mucinous and Non-Mucinous Colorectal Adenocarcinoma in Isfahan, Iran
by: Mehdi Nikbahkt Dastjerdi
Published: (2010-03-01)

Analysis of TP53 Codon 72 Gene Polymorphism in Patients with Endometriosis in Isfahan
by: Mehdi Nikbakht Dastjerdi, et al.
Published: (2011-12-01)

The frequency of TP53 R72P and MDM2 309T>G polymorphisms in Iranian infertile men with spermatogenetic failure: A case-control study
by: Zeinab Ebrahim Abadi, et al.
Published: (2018-08-01)

Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.
by: Keith R Loeb, et al.
Published: (2012-01-01)

Polimorfismo do gene tp53 no códon 72 em pacientes com suspeita de LMC Codon 72 polymorphism of the TP53 gene in patients suspected to have CML
by: Camila S. Hamú, et al.
Published: (2007-12-01)

Cancer Risk Assessment of Germline TP53, MDM2 SNP309 and Sex in a Family Study of Li-Fraumeni Syndrome
by: HsinHung, et al.
Published: (2018)

<it>MDM2 </it>SNP309 promoter polymorphism and <it>p53 </it>mutations in urinary bladder carcinoma stage T1
by: Olsson Hans, et al.
Published: (2013-01-01)

TP53 Gene Alterations including Codon 72 Polymorphism in Patients with Multiple Myeloma
by: Perumal Govindasamy, et al.
Published: (2018-02-01)

TP53 Codon 72 Polymorphism and P53 Protein Expression in Colorectal Cancer Specimens in Isfahan
by: Mehdi Nikbahkt Dastjerdi
Published: (2011-02-01)

TP53 codon 72 Polymorphism and P53 Protein Expression in Colorectal Cancer Specimens in Isfahan
by: Mehdi Nikbahkt Dastjerdi
Published: (2011-02-01)

The TP53 Codon 72 Polymorphism and Risk of Sporadic Prostate Cancer among Iranian Patients.
by: Farhad Babaei, et al.
Published: (2014-04-01)

Evidence for an association of TP53 codon 72 polymorphism with sporadic colorectal cancer risk in Isfahan
by: Mehdi Nikbakht Dastjerdi, et al.
Published: (2008-12-01)

Protein Expression and Codon 72 Polymorphism of TP53 Gene in Triple Negative Breast Cancer
by: Leandra Fiori Lopes, et al.
Published: (2014-12-01)

Análise do polimorfismo no códon 72 do gene TP53 em mulheres inférteis com e sem endometriose Analysis of codon 72 polymorphism of the TP53 gene in infertile women with and without endometriosis
by: Bianca Bianco, et al.
Published: (2011-01-01)

Study of Codon 72 Polymorphism of TP53 Gene in Cervical Biopsies with Abnormal Histology in Bushehr Province
by: Marzeah Zaker Hosseini, et al.
Published: (2018-04-01)

TP53 codon 72 polymorphism as a risk factor for cardiovascular disease in a Brazilian population
by: M.A.C. Smith, et al.
Published: (2007-11-01)

Meta-Analysis Results on the Association Between TP53 Codon 72 Polymorphism With the Susceptibility to Oral Cancer
by: Ying-Mei Lin, et al.
Published: (2018-08-01)

The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females
by: Jainagul Isakova, et al.
Published: (2017-11-01)

Study of MDM2 Promoter Polymorphism(SNP309) in Breast Cancer Patients in an Iranian Population
by: M Hossein Pour Feizi, et al.
Published: (2011-08-01)

An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk.
by: Xue Qin, et al.
Published: (2013-01-01)

Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls
by: Cai Lei, et al.
Published: (2009-08-01)

Study of the TP53 codon 72 polymorphism in oral cancer and oral potentially malignant disorders in Argentine patients
by: Ana Maria Zarate, et al.
Published: (2017-04-01)

MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.
by: Yong Ma, et al.
Published: (2013-01-01)

TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer.
by: Takashi Kawahara, et al.
Published: (2019-01-01)

Importance of <it>TP53 codon 72 and intron 3 duplication 16bp </it>polymorphisms in prediction of susceptibility on breast cancer
by: Medeiros Rui, et al.
Published: (2008-01-01)

Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study
by: Kao Wei-Tsung, et al.
Published: (2009-12-01)

Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers
by: Johnson Peter W, et al.
Published: (2006-03-01)

Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers
by: Copson, Ellen R., et al.
Published: (2006)

p53 Codon 72 Polymorphism and Risk of Cervical Cancer
by: JOSÉ M OJEDA, et al.
Published: (2003-01-01)

TP53 Codon 72 Heterozygosity May Promote MicrosatelliteInstability in Sporadic Colorectal Cancer
by: Mehdi Nikbahkt Dastjerdi, et al.
Published: (2010-01-01)

Evidence for an epistatic effect between TP53 R72P and MDM2 T309G SNPs in HIV infection: a cross-sectional study in women from South Brazil.
by: Fernando Pires Hartwig, et al.
Published: (2014-01-01)

Association between TP53 codon 72 G>C Polymorphism and Thyroid Carcinoma Risk: an Up-to-Date Meta-Analysis
by: Hossein Neamatzadeh
Published: (2017-01-01)

<it>MDM2 </it>gene SNP309 T/G and <it>p53 </it>gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians
by: Landt Olfert, et al.
Published: (2008-04-01)

Differentiating TP53 Mutation Status in Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI-Derived Radiomics
by: Jing Gao, et al.
Published: (2021-05-01)

Association of mRNA expression of TP53 and the TP53 codon 72 Arg/Pro gene polymorphism with colorectal cancer risk in Asian population: a bioinformatics analysis and meta-analysis
by: Dong ZY, et al.
Published: (2018-05-01)

P53 codon 11, 72, and 248 gene polymorphisms in endometriosis
by: Yao-Yuan Hsieh , Chich-Sheng Lin
Published: (2006-01-01)